NPS Pharmaceuticals

Banking on Biotech
CNBC
Sat, 01/12/13 - 10:33 am
Regeneron
Biogen Idec
Acorda Therapeutics
Sanofi
Celgene
Alexion
Biomarin
NPS Pharmaceuticals
Cerner
EXACT Sciences
Pfizer
Bristol-Myers Squibb
Eli Lilly
NPS Pharma: Controversy Over Super-Expensive Orphan Drug Prices
The Street
Thu, 01/3/13 - 03:51 pm
NPS Pharmaceuticals
Drug
pric
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Eisai
Sarepta
Arena Pharmaceuticals
Amarin
Gilead
Biomarin
Onyx
Medivation
Achillion
Incyte
Cell Therapeutics
Celgene
NPS Pharmaceuticals
Aegerion
Roche
Biogen Idec
Ariad Pharmaceuticals
Alexza
Navidea
Aveo
A Comprehensive Analysis Of NPS Pharmaceuticals
Seeking Alpha
Wed, 12/26/12 - 09:29 pm
NPS Pharmaceuticals
4 FDA Approvals in 1 Day
Motley Fool
Wed, 12/26/12 - 09:30 am
FDA
drug approvals
Roche
Tamiflu
Gilead Sciences
Gattex
NPS Pharmaceuticals
Alexza
Adasuve
VariZIG
Cangene
Drug Approvals Are Priced In, Wait For The Buying Opportunity
Seeking Alpha
Mon, 12/24/12 - 10:32 am
drug approvals
Arena Pharmaceuticals
Vivus
NPS Pharmaceuticals
Alexza
NPS Gattex Wins Approval for Short-Bowel Syndrome
Bloomberg
Sat, 12/22/12 - 12:19 pm
Gattex
short bowel syndrome
NPS Pharmaceuticals
3 Things to Watch at NPS Pharmaceuticals
Motley Fool
Thu, 12/6/12 - 10:48 am
NPS Pharmaceuticals
Gattex
Natpara
NPS Pharma Drifts Higher On Potential Orphan Drug Approval
Seeking Alpha
Tue, 12/4/12 - 01:33 pm
NPS Pharmaceuticals
orphan drugs
short bowel syndrome
Gattex
Celgene, NPS Pharmaceuticals, Amarin, J&J, Medivation Among Stocks to Watch in December
Minyanville
Fri, 11/30/12 - 04:28 pm
NPS Pharmaceuticals
Medivation
JNJ
Celgene
Amarin
This Week in Biotech
Motley Fool
Sun, 10/21/12 - 10:47 am
Aegerion
Isis Pharmaceuticals
Sanofi
NPS Pharmaceuticals
Aeterna Zentaris
FDA panel votes to support NPS Pharma bowel drug
Yahoo/AP
Wed, 10/17/12 - 11:55 am
NPS Pharmaceuticals
FDA
short bowel syndrome
Gattex
advisory panels
NPS shares halted as FDA panel reviews bowel drug
Yahoo/AP
Tue, 10/16/12 - 11:52 am
NPS Pharmaceuticals
FDA
advisory panels
Gattex
short bowel syndrome
NPS Pharmaceuticals: Buy If There Is A Dip
Seeking Alpha
Sun, 10/14/12 - 11:06 am
NPS Pharmaceuticals
Gattex
short bowel syndrome
Biotech Weekend Recap: Clinical Trials, Company Files
Seeking Alpha
Sun, 10/14/12 - 11:04 am
Eli Lilly
Valeant Pharmaceuticals
Lexicon Pharmaceuticals
Sarepta Therapeutics
Amarin
NPS Pharmaceuticals
Aeterna Zentaris
2 Biotech Stocks Ready To Flourish In The Wake Of Very Significant FDA News
Seeking Alpha
Sun, 10/14/12 - 11:02 am
Celgene
NPS Pharmaceuticals
lung cancer
Abraxane
Gattex
short bowel syndrome
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 10/13/12 - 12:07 pm
Vivus
Affymax
NPS Pharmaceuticals
NPS Pharma jumps ahead of Gattex FDA review
Yahoo/AP
Sat, 10/13/12 - 12:01 pm
NPS Pharmaceuticals
Gattex
short bowel syndrome
3 Biotechs Facing the Firing Squad Next Week
Motley Fool
Thu, 10/11/12 - 05:42 pm
Gattex
NPS Pharmaceuticals
lomitapide
Aegerion
Sanofi
Isis Pharmaceuticals
mipomersen
NPS Pharma: Gattex FDA Panel Preview
TheStreet.com
Thu, 10/11/12 - 10:24 am
Gattex
advisory panels
NPS Pharmaceuticals
FDA

Pages